(Q39247939)

10 September 2017

title

Serological responses of Gambian children to immunization with the malaria vaccine SPf66. (English)

1 reference

10 September 2017

0 references

0 references

1 reference

1 reference

8

Greenwood BM

1 reference

10 September 2017

Metzger WG

1

1 reference

10 September 2017

Haywood M

2

1 reference

10 September 2017

D'Alessandro U

3

1 reference

10 September 2017

Drakeley CJ

4

1 reference

10 September 2017

Weiss H

5

1 reference

10 September 2017

Bojang K

6

1 reference

10 September 2017

Targett GA

7

1 reference

10 September 2017

language of work or name

1 reference

1 July 1999

1 reference

10 September 2017

1 reference

10 September 2017

volume

21

1 reference

10 September 2017

issue

7

1 reference

10 September 2017

page(s)

335-340

1 reference

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

An efficacy trial of the malaria vaccine SPf66 in Gambian infants--second year of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

Efficacy trial of malaria vaccine SPf66 in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

Characterization of SPf(66)n: a chimeric molecule used as a malaria vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.1999.00231.X

10.1046/J.1365-3024.1999.00231.X

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference